Dyslipidemia Intervention in Metabolic Syndrome: Emphasis on Improving Lipids and Clinical Event Reduction Article

Full Text via DOI: 10.1097/MAJ.0b013e31821483fa PMID: 21519201 Web of Science: 000289884600011

Cited authors

  • Lavie, Carl J.; Milani, Richard V.; O'Keefe, James H.


  • The metabolic syndrome is a common disorder characterized by central (especially intra-abdominal) obesity, hypertension, impaired glucose tolerance and atherogenic dyslipidemia (including the combination of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol). In this article, the authors review interventions to improve this lipid profile and potentially reduce the risk of major cardiovascular events in patients with metabolic syndrome.

Publication date

  • 2011

International Standard Serial Number (ISSN)

  • 0002-9629

Start page

  • 388

End page

  • 393


  • 341


  • 5